These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2470917)
1. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. Matsuyama T; Hamamoto Y; Soma G; Mizuno D; Yamamoto N; Kobayashi N J Virol; 1989 Jun; 63(6):2504-9. PubMed ID: 2470917 [TBL] [Abstract][Full Text] [Related]
2. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production. Locardi C; Petrini C; Boccoli G; Testa U; Dieffenbach C; Buttò S; Belardelli F J Virol; 1990 Dec; 64(12):5874-82. PubMed ID: 1700829 [TBL] [Abstract][Full Text] [Related]
3. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Kobayashi N; Hamamoto Y; Yamamoto N; Ishii A; Yonehara M; Yonehara S Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9620-4. PubMed ID: 1702216 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. Mellors JW; Griffith BP; Ortiz MA; Landry ML; Ryan JL J Infect Dis; 1991 Jan; 163(1):78-82. PubMed ID: 1984479 [TBL] [Abstract][Full Text] [Related]
5. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha. Brinchmann JE; Gaudernack G; Vartdal F J Acquir Immune Defic Syndr (1988); 1991; 4(5):480-8. PubMed ID: 1673156 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro. Ito M; Baba M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; De Clercq E Biochem Biophys Res Commun; 1989 Jan; 158(1):307-12. PubMed ID: 2912452 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor. Hamamoto Y; Matsuyama T; Yamamoto N; Kobayashi N Cancer Res; 1990 Sep; 50(17):5287-90. PubMed ID: 2386936 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? Biswas P; Poli G; Orenstein JM; Fauci AS J Virol; 1994 Apr; 68(4):2598-604. PubMed ID: 7511175 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro. Ito M; Baba M; Mori S; Hirabayashi K; Sato A; Shigeta S; De Clercq E Biochem Biophys Res Commun; 1990 Feb; 166(3):1095-101. PubMed ID: 1689569 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. Matsuyama T; Yoshiyama H; Hamamoto Y; Yamamoto N; Soma G; Mizuno D; Kobayashi N AIDS Res Hum Retroviruses; 1989 Apr; 5(2):139-46. PubMed ID: 2785393 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133 [TBL] [Abstract][Full Text] [Related]
13. Cytokine enhancement of simian immunodeficiency virus (SIV/mac) from a chronically infected cloned T-cell line (HuT-78). Lairmore MD; Post AA; Goldsmith CS; Folks TM Arch Virol; 1991; 121(1-4):43-53. PubMed ID: 1722091 [TBL] [Abstract][Full Text] [Related]
14. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485 [TBL] [Abstract][Full Text] [Related]
15. Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. Salmon SE; Soehnlen B; Dalton WS; Meltzer P; Scuderi P Blood; 1989 Oct; 74(5):1723-7. PubMed ID: 2790197 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha stimulates both apical and basal production of HIV in polarized human intestinal HT29 cells. Fantini J; Bolmont C; Yahi N Immunol Lett; 1992 Sep; 34(1):85-90. PubMed ID: 1282499 [TBL] [Abstract][Full Text] [Related]
17. Generation of endogenous tumour necrosis factor-alpha in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection. Fujinaga K; Nakaya T; Ikuta K J Gen Virol; 1998 Feb; 79 ( Pt 2)():221-9. PubMed ID: 9472606 [TBL] [Abstract][Full Text] [Related]
18. Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. Chowdhury IH; Munakata T; Koyanagi Y; Kobayashi S; Arai S; Yamamoto N Biochem Biophys Res Commun; 1990 Aug; 170(3):1365-70. PubMed ID: 2390096 [TBL] [Abstract][Full Text] [Related]